The results suggest that NOX4 appears to have an important effect on survival in patients with low lymph node metastases and in patients with carcinoembryonic antigen (CEA) negative (Figure 3D). Here, CEACAM5 is linked to metastatic malignant neoplasm in the lymph nodes.